Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Helme

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Multiple Sclerosis and Related Disorders|April 3, 2022
The agenda of the global patient reported outcomes for multiple sclerosis (PROMS) initiative: Progresses and open questionsPaola Zaratin, Patrick Vermersch, Maria Pia Amato, et al.
Multiple Sclerosis and Related Disorders|December 2, 2025
Recommendations for the use of off-label rituximab for the treatment of multiple sclerosis in low-resource settingsNick Rijke, Bassem I Yamout, Deanna Saylor, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 1, 2021
Charting a global research strategy for progressive MS-An international progressive MS Alliance proposalAlan J Thompson, William Carroll, Olga Ciccarelli, et al.
Nature Reviews. Neurology|July 15, 2022
From the prodromal stage of multiple sclerosis to disease preventionRuth Ann Marrie, Mark Allegretta, Lisa F Barcellos, et al.
Frontiers in Neurology|July 8, 2024
The global patient-reported outcomes for multiple sclerosis initiative: bridging the gap between clinical research and care - updates at the 2023 plenary eventPaola Zaratin, Sara Samadzadeh, Meral Seferoğlu, et al.
The Lancet. Global Health|March 14, 2024
National plans and awareness campaigns as priorities for achieving global brain healthSebastian F Winter, Donna Walsh, Coriene Catsman-Berrevoets, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 1, 2025
Recommendations for essential medicines for multiple sclerosis in low-resource settingsDeanna Saylor, Nick Rijke, Jennifer McDonell, et al.
Multiple Sclerosis and Related Disorders|August 2, 2022
Severity of COVID19 infection among patients with multiple sclerosis treated with interferon-βSteve Simpson-Yap, Ashkan Pirmani, Edward De Brouwer, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 29, 2022
Updated Results of the COVID-19 in MS Global Data Sharing Initiative: Anti-CD20 and Other Risk Factors Associated With COVID-19 SeveritySteve Simpson-Yap, Ashkan Pirmani, Tomas Kalincik, et al.
Nature Reviews. Neurology|May 19, 2023
Global synergistic actions to improve brain health for human developmentMayowa O Owolabi, Matilde Leonardi, Claudio Bassetti, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Multiple Sclerosis and Related Disorders|April 3, 2022
The agenda of the global patient reported outcomes for multiple sclerosis (PROMS) initiative: Progresses and open questionsPaola Zaratin, Patrick Vermersch, Maria Pia Amato, et al.
Multiple Sclerosis and Related Disorders|December 2, 2025
Recommendations for the use of off-label rituximab for the treatment of multiple sclerosis in low-resource settingsNick Rijke, Bassem I Yamout, Deanna Saylor, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 1, 2021
Charting a global research strategy for progressive MS-An international progressive MS Alliance proposalAlan J Thompson, William Carroll, Olga Ciccarelli, et al.
Nature Reviews. Neurology|July 15, 2022
From the prodromal stage of multiple sclerosis to disease preventionRuth Ann Marrie, Mark Allegretta, Lisa F Barcellos, et al.
Frontiers in Neurology|July 8, 2024
The global patient-reported outcomes for multiple sclerosis initiative: bridging the gap between clinical research and care - updates at the 2023 plenary eventPaola Zaratin, Sara Samadzadeh, Meral Seferoğlu, et al.
The Lancet. Global Health|March 14, 2024
National plans and awareness campaigns as priorities for achieving global brain healthSebastian F Winter, Donna Walsh, Coriene Catsman-Berrevoets, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 1, 2025
Recommendations for essential medicines for multiple sclerosis in low-resource settingsDeanna Saylor, Nick Rijke, Jennifer McDonell, et al.
Multiple Sclerosis and Related Disorders|August 2, 2022
Severity of COVID19 infection among patients with multiple sclerosis treated with interferon-βSteve Simpson-Yap, Ashkan Pirmani, Edward De Brouwer, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 29, 2022
Updated Results of the COVID-19 in MS Global Data Sharing Initiative: Anti-CD20 and Other Risk Factors Associated With COVID-19 SeveritySteve Simpson-Yap, Ashkan Pirmani, Tomas Kalincik, et al.
Nature Reviews. Neurology|May 19, 2023
Global synergistic actions to improve brain health for human developmentMayowa O Owolabi, Matilde Leonardi, Claudio Bassetti, et al.
Pageof 2